Slaughter and May is advising Temasek - investment as part of a consortium in Alvogen

Slaughter and May is supporting the legal team at Temasek, the Singapore-based investment company, on Temasek's investment, as part of a consortium alongside CVC Capital Partners and others, in Alvogen, the generic pharmaceutical company.

Nigel Boardman Senior Consultant
Steve Edge Partner